Bunge Global SA Files 8-K

Ticker: BG · Form: 8-K · Filed: 2025-05-02T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, sec-filing

TL;DR

Bunge Global SA filed a routine 8-K on 5/2/25. No major news.

AI Summary

Bunge Global SA filed an 8-K on May 2, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material changes, but rather serves as a standard disclosure.

Why It Matters

This filing indicates Bunge Global SA is making a required disclosure to the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K disclosure with no new material information that would immediately impact the company's risk profile.

Key Players & Entities

Bunge Global SA (company) — Registrant
May 2, 2025 (date) — Date of Report

FAQ

What is the purpose of this 8-K filing by Bunge Global SA?

This 8-K filing serves as a Current Report for Bunge Global SA, reporting "Other Events" and "Financial Statements and Exhibits" as of May 2, 2025.

What specific "Other Events" are detailed in this filing?

The provided text of the filing does not specify the details of the "Other Events" beyond listing it as an item information.

Are there any new financial statements or exhibits attached to this filing?

The filing lists "Financial Statements and Exhibits" as an item information, but the specific content of these exhibits is not detailed in the provided text.

What is Bunge Global SA's state of incorporation and fiscal year end?

Bunge Global SA is incorporated in Switzerland and its fiscal year ends on December 31.

What are the principal executive offices and corporate headquarters addresses for Bunge Global SA?

The principal executive offices are located at Route de Florissant 13, 1206 Geneva, Switzerland, and the corporate headquarters are at 1391 Timberlake Manor Parkway, Chesterfield, MO 63017.

From the Filing

0001996862-25-000082.txt : 20250502 0001996862-25-000082.hdr.sgml : 20250502 20250502080521 ACCESSION NUMBER: 0001996862-25-000082 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250502 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250502 DATE AS OF CHANGE: 20250502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bunge Global SA CENTRAL INDEX KEY: 0001996862 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] ORGANIZATION NAME: 04 Manufacturing EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56607 FILM NUMBER: 25905551 BUSINESS ADDRESS: STREET 1: ROUTE DE FLORISSANT 13 CITY: GENEVA STATE: V8 ZIP: 1206 BUSINESS PHONE: 41 22 592 91 00 MAIL ADDRESS: STREET 1: ROUTE DE FLORISSANT 13 CITY: GENEVA STATE: V8 ZIP: 1206 8-K 1 bg-20250502.htm 8-K bg-20250502 0001996862 false 0001996862 2025-05-02 2025-05-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2025 Date of Report (date of earliest event reported) ___________________________________ BUNGE GLOBAL SA (Exact name of registrant as specified in its charter) ___________________________________ Switzerland (State of Incorporation) 000-56607 (Commission File Number) 98-1743397 (IRS Employer Identification Number) Route de Florissant 13 , 1206 Geneva , Switzerland N.A. (Address of principal executive offices and zip code) (Zip Code) 1391 Timberlake Manor Parkway Chesterfield, MO  63017 (Address of corporate headquarters ) (Zip Code) ( 314 ) 292-2000 (Registrant's telephone number, including area code) N.A. (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Registered Shares, $0.01 par value per share BG New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events On May 2, 2025, Bunge Global SA (“Bunge”) announced that its wholly-owned subsidiary, Bunge Limited Finance Corp. (“BLFC”), further extended the expiration date of its previously announced (A) offers to exchange (collectively, the “Exchange Offers”) any and all outstanding 2.000% Notes due 2026 (the “Existing Viterra 2026 Notes”), 4.900% Notes due 2027 (the “Existing Viterra 2027 Notes”), 3.200% Notes due 2031 (the “Existing Viterra 2031 Notes”), and 5.250% Notes due 2032 (the “Existing Viterra 2032 Notes”, and with the Existing Viterra 2026 Notes, the Existing Viterra 2027 Notes and the Exis